filo
Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) rallied 36% on Friday, the day after the company released a Q3 earnings report that beat Street estimates on both the top and bottom lines.
Late Thursday, Rigel reported adjusted EPS of $0.70, which topped consensus estimates